Egetis Therapeutics AB (publ) (EGTX) — Cash Flow-to-Debt Ratio
Egetis Therapeutics AB (publ) (EGTX) has a Cash Flow-to-Debt Ratio of -0.22x as of March 2026, meaning its operating cash flow of Skr-64.30 Million could theoretically repay 0% of its total liabilities (Skr288.70 Million) in one year. See EGTX financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Egetis Therapeutics AB (publ) Cash Flow-to-Debt Ratio (2010–2025)
Historical debt coverage capacity for Egetis Therapeutics AB (publ) across 16 annual periods. For the full cash flow conversion analysis, see how efficiently does Egetis Therapeutics AB (publ) generate cash.
Annual Cash Flow-to-Debt Ratio for Egetis Therapeutics AB (publ) (2010–2025)
Year-by-year debt coverage analysis for Egetis Therapeutics AB (publ). Check cash flow quality index of Egetis Therapeutics AB (publ) to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.89x | Skr-267.10 Million | Skr300.40 Million | ▼ -16.8% |
| 2024 | -0.76x | Skr-227.90 Million | Skr299.40 Million | ▲ +41.3% |
| 2023 | -1.30x | Skr-278.40 Million | Skr214.60 Million | ▲ +59.0% |
| 2022 | -3.16x | Skr-173.50 Million | Skr54.90 Million | ▼ -2.6% |
| 2021 | -3.08x | Skr-130.11 Million | Skr42.23 Million | ▼ -504.9% |
| 2020 | -0.51x | Skr-134.64 Million | Skr264.34 Million | ▲ +79.5% |
| 2019 | -2.49x | Skr-62.64 Million | Skr25.20 Million | ▲ +29.8% |
| 2018 | -3.54x | Skr-80.31 Million | Skr22.68 Million | ▲ +52.3% |
| 2017 | -7.42x | Skr-86.55 Million | Skr11.66 Million | ▼ -41.3% |
| 2016 | -5.25x | Skr-36.12 Million | Skr6.87 Million | ▲ +55.5% |
| 2015 | -11.82x | Skr-51.15 Million | Skr4.33 Million | ▼ -265.8% |
| 2014 | -3.23x | Skr-41.38 Million | Skr12.81 Million | ▲ +53.3% |
| 2013 | -6.92x | Skr-28.07 Million | Skr4.06 Million | ▼ -41.1% |
| 2012 | -4.90x | Skr-31.96 Million | Skr6.52 Million | ▼ -32.6% |
| 2011 | -3.70x | Skr-14.40 Million | Skr3.89 Million | ▼ -104.5% |
| 2010 | -1.81x | Skr-2.72 Million | Skr1.50 Million | — |